Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions

Go back to Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
(NASDAQ: IPSC) Delayed: 2.30 +0.01 (0.44%)
Previous Close $2.29    52 Week High
Open $2.29    52 Week Low
Day High $2.41    P/E N/A 
Day Low $2.27    EPS
Volume 965,290